Mantle cell lymphoma (MCL) is a lymphoid malignant neoplasm of mature pregerminal center naive B cells that express CD5, surface IgM, and surface IgD, but not CD23. The hallmark of this lymphoma is overexpression of cyclin D1, attributable to t(11;14)(q13;q32) causing juxtaposition of the bcl-1 (cyclin D1) gene to the immunoglobulin heavy chain gene, or other mechanisms deregulating the bcl-1 gene. 1 Besides the classic type characterized by small cells with hyperchromatic nuclei, the blastoid and pleomorphic variants also have been recognized. 2,3 Peripheral blood and bone marrow involvement is not uncommon in MCL during the course of disease. 4 In a report on the cytologic findings of MCL manifesting with a leukemic phase, Wong et al 5 observed in 1 patient the occurrence of leukemic cells that superficially resembled oversized prolymphocytes. We since have observed 3 additional cases with this unusual cytologic appearance. We therefore performed a comprehensive cytologic, histologic, and immunologic analysis on these 4 cases.
Chronic lymphoproliferative disorders sometimes can be difficult to classify. We report 4 Mantle cell lymphoma (MCL) is a lymphoid malignant neoplasm of mature pregerminal center naive B cells that express CD5, surface IgM, and surface IgD, but not CD23. The hallmark of this lymphoma is overexpression of cyclin D1, attributable to t(11;14)(q13;q32) causing juxtaposition of the bcl-1 (cyclin D1) gene to the immunoglobulin heavy chain gene, or other mechanisms deregulating the bcl-1 gene. 1 Besides the classic type characterized by small cells with hyperchromatic nuclei, the blastoid and pleomorphic variants also have been recognized. 2, 3 Peripheral blood and bone marrow involvement is not uncommon in MCL during the course of disease. 4 In a report on the cytologic findings of MCL manifesting with a leukemic phase, Wong et al 5 observed in 1 patient the occurrence of leukemic cells that superficially resembled oversized prolymphocytes. We since have observed 3 additional cases with this unusual cytologic appearance. We therefore performed a comprehensive cytologic, histologic, and immunologic analysis on these 4 cases.
Materials and Methods

Case Selection
During the period July 1994 to December 2000, 20 patients were given a diagnosis of leukemic MCL at the Queen Elizabeth Hospital, Hong Kong, People's Republic of China. The diagnosis of MCL was established based on an immunophenotype of CD5+ CD19+ CD23-and overexpression of cyclin D1. This was supplemented by lymph node histologic features and cytogenetic findings of t(11;14)(q13;q32). The 4 cases included in the study all
The blood films and bone marrow aspirate smears were stained with May-Grünwald Giemsa. Lymph node biopsy specimens from all 4 cases and trephine biopsy specimens from cases 1 through 3 were available for study. Specimens were formalin fixed, paraffin embedded, sectioned, and stained with H&E. The trephine biopsy specimens were decalcified in EDTA.
Immunohistochemical Studies
Sections cut from the lymph node biopsy specimens were immunostained with the following monoclonal antibodies: NCL-CD5-4C7 to CD5 (Novocastra, Newcastleupon-Tyne, England); NCL-CD23-1B12 to CD23 (Novocastra); DCS-6 to cyclin D1 (Ventana, Tucson, AZ); 1F8 and Ber-MAC-DRC to CD21 and CD35, respectively, to highlight the follicular dendritic cell meshwork (Dakopatts, Glostrup, Denmark); and DO-7 to p53 protein (Dakopatts). The streptavidin-biotin-peroxidase complex detection system was used, using the Ventana ES automated immunostainer. Antigen retrieval was achieved by heating the slides in EDTA buffer at pH 8 in a pressure cooker for 2.5 minutes. An appropriate positive control was mounted on every slide to ascertain the validity of the stain.
Results
Clinical Findings
The patients were 3 men and 1 woman. Their mean age was 67.8 years (range, 65-73 years), and they had generalized lymphadenopathy and massive splenomegaly at the initial examination ❚Table 1❚. The peripheral blood counts showed leukocytosis (13,900-50.900/µL [13.9-50.9 × 10 9 /L]) with a WBC count around 50,000/µL (50 × 10 9 /L) in 2 patients. Circulating mantle cells accounted for 40% to 66% of the leucocytes (mean, 54%). Cytogenetic studies showed complex chromosomal abnormalities with t(11;14)(q13;q32) in 3 patients ❚Image 1❚. All of them were treated with combination chemotherapy that included cyclophosphamide, vincristine, and prednisolone with poor response. Three patients died in 6 weeks to 13 months (mean, 6 months), while 1 patient was alive with disease after 5 months.
Cytologic Findings
In all 4 cases, the abnormal circulating lymphoid cells were predominantly (>90%) large cells (3-4 times the size of an RBC) and had round, angular to irregular nuclei with slightly clumped chromatin; a prominent, often single nucleolus; and a fair amount of pale basophilic cytoplasm ❚Image 2❚. Occasional giant cells (>4 times the size of an RBC) with markedly folded nuclei, multiple nucleoli, and only a narrow rim of cytoplasm could be found in cases 2 through 4 (Image 2C). In the marrow aspirate smears, similar large cells were found and accounted for about 50% of the marrow nucleated cells (range, 20%-69%) ❚Image 3A❚. 
Histologic Findings
The lymph node architecture was effaced by a vaguely nodular to diffuse infiltrate of small to medium-sized lymphoid cells that had irregular to folded nuclei, mixed with some larger cells with a single and distinct nucleolus ❚Image 4A❚. Prolymphocytes, paraimmunoblasts, and proliferation centers were not found. The trephine biopsy specimens showed an interstitial to nodular infiltrate of a mixed population of small, medium to large cells with prominent nuclear irregularities ❚Image 3B❚. No paratrabecular accentuation was demonstrated.
Immunohistochemical Findings
The lymphoma cells expressed CD5 but not CD23. Strong nuclear staining for cyclin D1 ❚Image 4B❚ also was demonstrated. p53 protein was positive only in case 2. In all 4 cases, irregular meshwork of follicular dendritic cells could be highlighted by simultaneous staining for CD21 and CD35. 
Discussion
MCL was first characterized in the Kiel Classification in 1974 as "centrocytic lymphoma." 6 It was not until the early 1990s that the term "mantle cell lymphoma" was used to specify a mature B-cell lymphoma with a distinctive immunophenotype of CD5+ CD23-, translocation t(11;14)(q13;q32), and overexpression of the cyclin D1 gene. 7 Cyclin D1 overexpression has become a defining feature and also has helped in recognizing the broader morphologic spectrum of MCL. Cytologically, the mantle cells often are described as being small to medium-sized with clefted nuclei and scanty cytoplasm. The leukemic form of mantle cell lymphoma has also been described. 5, 8, 9 In the present report, we describe the unusual cytologic findings in 4 cases of pleomorphic variant of MCL in leukemic phase characterized by prominent single nucleoli. Unlike the variant form of hairy cell leukemia ❚Image 5A❚, the leukemic mantle cells have less condensed chromatin and do not show cytoplasmic projections. 10 The nucleolated leukemic mantle cells resemble oversized prolymphocytes because of the presence of a single central nucleolus and an appreciable amount of pale cytoplasm, but the nuclear/cytoplasmic ratio is higher ❚Image 5B❚. Cytologically, this type of leukemic MCL can be distinguished from prolymphocytic leukemia by the large size of the circulating tumor cells. The presence of giant hyperlobulated cells with a high nuclear/cytoplasmic ratio on careful scrutiny of the blood films also may help in the differentiation. Furthermore, the clinical manifestations are unusual for prolymphocytic leukemia, which usually is associated with splenomegaly but no peripheral lymphadenopathy. 1, 11 The tumor cells showed an immunophenotypic profile of CD5+ CD23-, and all of them exhibited overexpression of cyclin D1, with t(11;14)(q13;q32) demonstrated in 3 cases. Although cyclin D1 overexpression with or without the translocation t(11;14) has been described in occasional cases of chronic lymphocytic leukemia (CLL) or prolymphocytic leukemia, 12-14 lymph node histologic features, which are of great help for the differentiation between MCL and CLL, are lacking in most of the reported cases. In fact, it has been shown that a substantial proportion of cases previously classified as CLL with t(11;14)(q13;q32) should be reclassified as MCL or other entities on histologic examination of the lymph node or spleen. 15 Levy et al 16 described a subset of probable MCL-related tumors with tumor cells showing prominent nucleoli. Schlette et al 17 also suggested that some cases of cyclin D1-positive, t(11;14)-positive prolymphocytic leukemia should best be classified as "prolymphocytoid variant" MCL. It is unfortunate that a lymph node biopsy specimen was available in only 1 of the 4 cases reported by them. On the other hand, the availability of lymph node biopsy specimens in all 4 of our cases confirmed the diagnosis of MCL. The lymph nodes in both CLL and prolymphocytic leukemia usually contain paraimmunoblasts and pseudofollicular proliferation centers, 18, 19 features that were absent in our cases. Furthermore, irregular follicular dendritic cell meshwork, a characteristic histologic feature of MCL but not CLL or prolymphocytic leukemia, 20 can be found in our cases. 
